Skip to Main Content

Author Details

Darren Ennis
Ovarian Cancer Action Research Centre, Imperial College London
2004
35
21
PMIDPaper TitleJournal TitlePublished Year
36928279Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.JAMA Oncol2023
37752102Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37845213Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.Nat Commun2023
37474499The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
35131874Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma.Mol Cancer Ther2022
35398881The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.Clin Cancer Res2022
33570999FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.JCO Clin Cancer Inform2021
32195317NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer.Mol Ther Oncolytics2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
30835824Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.Cancer2019
30464341Mannose impairs tumour growth and enhances chemotherapy.Nature2018
30104763Copy number signatures and mutational processes in ovarian carcinoma.Nat Genet2018
29238045RIPK3 promotes adenovirus type 5 activity.Cell Death Dis2017
28198360Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.Nat Commun2017
28359078Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.Br J Cancer2017
28954785The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.Clin Cancer Res2017
26948875The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis.Curr Biol2016
27306793Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.Clin Cancer Res2016
27530326CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.Cancer Res2016
26681675Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.Ann Oncol2016
25560085Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.Mol Oncol2015
26807325Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma.Am J Cancer Res2015
26124480Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.J Clin Oncol2015
26240291Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.Clin Cancer Res2015
23825230Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer.FASEB J2013
22322968The peritoneal tumour microenvironment of high-grade serous ovarian cancer.J Pathol2012
22219323Production of TNF-α in macrophages activated by T cells, compared with lipopolysaccharide, uses distinct IL-10-dependent regulatory mechanism.J Immunol2012
19306979Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy.Am J Surg2010
20632267Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma.Br J Surg2010
20189371Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.Clin Oncol (R Coll Radiol)2010
19392848Building a bioresource for esophageal research: lessons from the early experience of an academic medical center.Dis Esophagus2010
15753254Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.Clin Diagn Lab Immunol2005
15626480Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma.Immunol Lett2005
15347385Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma.Clin Exp Allergy2004
  • 1 - 35 of 35

Recommended Authors

Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Shawn Anderson
University of British Columbia
Career Start Year 2009
Number of shared co-authors 2
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 9
Riyue Bao
UPMC Hillman Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Xi Liu
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 4
Francesc Castro-Giner
University of Basel and University Hospital Basel
Career Start Year 2006
Number of shared co-authors 4
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 0
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 5
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Rajesh K Soni
Herbert Irving Comprehensive Cancer Center, Columbia University
Career Start Year 2002
Number of shared co-authors 0
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 6
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 1
William J Howat
Cancer Research UK Cambridge Institute
Career Start Year 1994
Number of shared co-authors 14
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 4
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 0
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Robyn L Ward
University of Sydney
Career Start Year 1989
Number of shared co-authors 37
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 8
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 14
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 2
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 1
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Iain A McNeish
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 23
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 12
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 10
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 9
Teodora Goranova
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
Liz-Anne Lewsley
CRUK Clinical Trials Unit, University of Glasgow
Co-authored papers 7
Rosalind Glasspool
University of Glasgow
Co-authored papers 6
Naveena Singh
Barts Health NHS Trust
Co-authored papers 6
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 6
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 5
Matthew D Eldridge
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 4
Dilrini De Silva
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 4
Cyril B Gilks
University of British Columbia
Co-authored papers 3
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 3
Susana Banerjee
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 3
David G Huntsman
University of British Columbia
Co-authored papers 3
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers 2
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 2
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
Helen Steed
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 2
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 2
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 2
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 2
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 2
Chloe Karpinskyj
Institute of Clinical Trials and Methodology, University College London
Co-authored papers 2
Michael E Carney
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 2
Valerie Rhenius
University of Cambridge
Co-authored papers 2
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 2
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 2
Release 1.2